Gu et al [52] suggested that NFκB activation could play a role in the down-modulation of CYPs by inflammatory and infectious diseases and malaria was reported to enhance TLR-mediated pro-inflammatory responses [53]. This evidence concerns the gene NFKB1 and infectious disease.